Camperdown, NEW%20SOUTH%20WALES1 Active Studies

Multiple Sclerosis Clinical Trials in Camperdown, NEW%20SOUTH%20WALES

Find 1 actively recruiting multiple sclerosis clinical trials in Camperdown, NEW%20SOUTH%20WALES. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
400
Enrolling

Recruiting Multiple Sclerosis Studies in Camperdown

About Multiple Sclerosis Clinical Trials in Camperdown

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 1 multiple sclerosis clinical trials recruiting participants in Camperdown, NEW%20SOUTH%20WALES. These studies are seeking a combined 400 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Camperdown — FAQ

Are there multiple sclerosis clinical trials in Camperdown?

Yes, there are 1 multiple sclerosis clinical trials currently recruiting in Camperdown, NEW%20SOUTH%20WALES. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Camperdown?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Camperdown research site will contact you about next steps.

Are clinical trials in Camperdown free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Camperdown studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 1 active trials in Camperdown are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated March 2, 2026 from ClinicalTrials.gov